Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Fisch

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 8, 2024
Blood-based screening for HPV-associated cancersDipon Das, Shun Hirayama, Ling Aye, et al.
Journal of the National Cancer Institute|September 9, 2025
Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detectionDipon Das, Shun Hirayama, Ling Aye, et al.
Thyroid : Official Journal of the American Thyroid Association|July 14, 2024
<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid MalignancyMark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 22, 2026
Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV-Independent Head and Neck Squamous Cell CarcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Prognostic value of tumor-informed ctDNA in HPV-independent head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
The Journal of Molecular Diagnostics : JMD|July 7, 2023
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid TumorsHarrison K Tsai, Tasos Gogakos, Va Lip, et al.
Cancer Discovery|June 1, 2023
Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell CarcinomaRaj K Gopal, Venkata R Vantaku, Apekshya Panda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusionsLucas R Massoth, Yin P Hung, Valentina Nardi, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Science Translational Medicine|June 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Medrxiv : the Preprint Server for Health Sciences|February 8, 2024
Blood-based screening for HPV-associated cancersDipon Das, Shun Hirayama, Ling Aye, et al.
Journal of the National Cancer Institute|September 9, 2025
Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detectionDipon Das, Shun Hirayama, Ling Aye, et al.
Thyroid : Official Journal of the American Thyroid Association|July 14, 2024
<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid MalignancyMark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 22, 2026
Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV-Independent Head and Neck Squamous Cell CarcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Prognostic value of tumor-informed ctDNA in HPV-independent head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
The Journal of Molecular Diagnostics : JMD|July 7, 2023
Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid TumorsHarrison K Tsai, Tasos Gogakos, Va Lip, et al.
Cancer Discovery|June 1, 2023
Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell CarcinomaRaj K Gopal, Venkata R Vantaku, Apekshya Panda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusionsLucas R Massoth, Yin P Hung, Valentina Nardi, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Science Translational Medicine|June 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Pageof 5